NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
36.53
-0.47 (-1.27%)
Nov 4, 2025, 4:00 PM EST - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $4.11 billion as of November 5, 2025. Its market cap has increased by 140.18% in one year.
Market Cap
4.11B
Enterprise Value
3.33B
1-Year Change
140.18%
Ranking
Category
Stock Price
$36.53
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.11B, an increase of 2,563.86%. That is a compound annual growth rate of 99.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 4.17B | 51.47% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |